Dermatology
News, opinions and meeting coverage in dermatology.
— From scant data, the armamentarium is expanding, with an increasing evidence base
Latest in Dermatology
Adding tirzepatide helped patients shed pounds, improved complete skin clearance rates
A 21-year-old woman visited her doctor for multiple moles on her chest that first developed in her early teenage years and progressively increased in size and quantity over the years. Can you diagnose the patient?
The condition is now called polyendocrine metabolic ovarian syndrome
Health news and commentary gathered by MedPage Today staff
The condition is now called polyendocrine metabolic ovarian syndrome
Health news and commentary gathered by MedPage Today staff
Dermatology Case Studies
Incision sites were itchy, painful, red, and oozing and were not showing signs of healing
Just two of the multiple symptoms that began to emerge shortly after birth
Bedside skin punch biopsy proved crucial
More in Dermatology
Dose-response signal appears in phase II trial, and all doses are better than placebo
While ivermectin is recommended, optimal dosing has been unclear
Mounting evidence of improved outcomes as add-on to psoriasis drugs in patients with obesity
Data show many patients discontinue or switch treatment within the first year
The picture on this rare condition has been getting clearer
A 32-year-old man visited his doctor for a pustular eruption that developed within the last week. Can you diagnose the patient?
Studies suggest a way to call off the so-called atopic march
Are these skin care devices all hype, or are there science-backed benefits?
A postmarketing study will assess whether Radiesse interferes with breast imaging
Kelly Ripa recently discussed her attempt to stop her tush from aging
You passed medical training, now see if you can pass our weekly quiz
Responses include total clearance in up to 30% of patients treated with sonelokimab, povorcitinib
Historically good results with IL-4 inhibitors raise questions with U.S. audience
Three-fourths of patients have 70-75% improvement at 16 weeks with zasocitinib, envudeucitinib
Eight deaths and dozens of DILI cases linked to avacopan for ANCA-associated vasculitis
Adding tirzepatide to ixekizumab significantly improved primary and key secondary outcomes
Brepocitinib significantly boosts global, all secondary dermatomyositis scores in VALOR trial
Takes recent clinical trials, drug introductions into account
A 49-year-old man with a history of acute myeloid leukemia who received an allogeneic bone marrow transplant 2 weeks prior developed a widespread rash. Can you diagnose the patient?
Linerixibat approved for cholestatic itch in primary biliary cholangitis
Agency cites concerns raised in public comments; dermatologists emphasize risks for young people
Oral IL-23 inhibitor icotrokinra achieved near-complete skin clearance in two-thirds of patients
Twofold higher risk than general population, suicide more often preceded by episode of self-harm
Pooled data from PsA and axSpA extension studies provide early reassurance
Retrospective study finds link between blockbuster drugs and longer survival
"Our findings provide the best evidence available," researchers say
Kaposi sarcoma-associated herpesvirus testing is not routinely performed on donors or recipients
You passed medical training, now see if you can pass our weekly quiz
Ipilimumab-nivolumab also linked with better survival but more toxicity in small study
Does the President's annual physical report provide a clue?
Photos from at least as far back as last week show visible redness on the president's neck
Clothing choices, frequency and consistency of application figure into total cost
Black patients on Medicaid less likely to use the newer therapies
Difamilast demonstrated safety, efficacy in multiple eczema trials, joins crisaborole, roflumilast
